1022 related articles for article (PubMed ID: 33545090)
21. Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.
Poletti P; Tirani M; Cereda D; Trentini F; Guzzetta G; Sabatino G; Marziano V; Castrofino A; Grosso F; Del Castillo G; Piccarreta R; Andreassi A; Melegaro A; Gramegna M; Ajelli M; Merler S;
JAMA Netw Open; 2021 Mar; 4(3):e211085. PubMed ID: 33688964
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial.
Hosogaya N; Miyazaki T; Fukushige Y; Takemori S; Morimoto S; Yamamoto H; Hori M; Kurokawa T; Kawasaki Y; Hanawa M; Fujii Y; Hanaoka H; Iwami S; Watashi K; Yamagoe S; Miyazaki Y; Wakita T; Izumikawa K; Yanagihara K; Mukae H; Kohno S;
Trials; 2021 Apr; 22(1):309. PubMed ID: 33910617
[TBL] [Abstract][Full Text] [Related]
23. Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study.
Li F; Li YY; Liu MJ; Fang LQ; Dean NE; Wong GWK; Yang XB; Longini I; Halloran ME; Wang HJ; Liu PL; Pang YH; Yan YQ; Liu S; Xia W; Lu XX; Liu Q; Yang Y; Xu SQ
Lancet Infect Dis; 2021 May; 21(5):617-628. PubMed ID: 33476567
[TBL] [Abstract][Full Text] [Related]
24. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA
Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090
[TBL] [Abstract][Full Text] [Related]
26. Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity.
Stankiewicz Karita HC; Dong TQ; Johnston C; Neuzil KM; Paasche-Orlow MK; Kissinger PJ; Bershteyn A; Thorpe LE; Deming M; Kottkamp A; Laufer M; Landovitz RJ; Luk A; Hoffman R; Roychoudhury P; Magaret CA; Greninger AL; Huang ML; Jerome KR; Wener M; Celum C; Chu HY; Baeten JM; Wald A; Barnabas RV; Brown ER
JAMA Netw Open; 2022 Jan; 5(1):e2142796. PubMed ID: 35006245
[TBL] [Abstract][Full Text] [Related]
27. Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study.
Bhatt M; Plint AC; Tang K; Malley R; Huy AP; McGahern C; Dawson J; Pelchat M; Dawson L; Varshney T; Arnold C; Galipeau Y; Austin M; Thampi N; Alnaji F; Langlois MA; Zemek RL
CMAJ Open; 2022; 10(2):E357-E366. PubMed ID: 35414597
[TBL] [Abstract][Full Text] [Related]
28. Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis.
Madewell ZJ; Yang Y; Longini IM; Halloran ME; Dean NE
JAMA Netw Open; 2020 Dec; 3(12):e2031756. PubMed ID: 33315116
[TBL] [Abstract][Full Text] [Related]
29. Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain.
Suñer C; Ubals M; Tarín-Vicente EJ; Mendoza A; Alemany A; Hernández-Rodríguez Á; Casañ C; Descalzo V; Ouchi D; Marc A; Rivero À; Coll P; Oller X; Miguel Cabrera J; Vall-Mayans M; Dolores Folgueira M; Ángeles Melendez M; Agud-Dios M; Gil-Cruz E; Paris de Leon A; Ramírez Marinero A; Buhiichyk V; Galván-Casas C; Paredes R; Prat N; Sala Farre MR; Bonet-Simó JM; Farré M; Ortiz-Romero PL; Clotet B; García-Patos V; Casabona J; Guedj J; Cardona PJ; Blanco I; ; Marks M; Mitjà O
Lancet Infect Dis; 2023 Apr; 23(4):445-453. PubMed ID: 36521505
[TBL] [Abstract][Full Text] [Related]
30. Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study.
Hakki S; Zhou J; Jonnerby J; Singanayagam A; Barnett JL; Madon KJ; Koycheva A; Kelly C; Houston H; Nevin S; Fenn J; Kundu R; Crone MA; Pillay TD; Ahmad S; Derqui-Fernandez N; Conibear E; Freemont PS; Taylor GP; Ferguson N; Zambon M; Barclay WS; Dunning J; Lalvani A;
Lancet Respir Med; 2022 Nov; 10(11):1061-1073. PubMed ID: 35988572
[TBL] [Abstract][Full Text] [Related]
31. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
32. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
[TBL] [Abstract][Full Text] [Related]
33. Factors Associated With Household Transmission of SARS-CoV-2: An Updated Systematic Review and Meta-analysis.
Madewell ZJ; Yang Y; Longini IM; Halloran ME; Dean NE
JAMA Netw Open; 2021 Aug; 4(8):e2122240. PubMed ID: 34448865
[TBL] [Abstract][Full Text] [Related]
34. Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial.
Young BC; Eyre DW; Kendrick S; White C; Smith S; Beveridge G; Nonnenmacher T; Ichofu F; Hillier J; Oakley S; Diamond I; Rourke E; Dawe F; Day I; Davies L; Staite P; Lacey A; McCrae J; Jones F; Kelly J; Bankiewicz U; Tunkel S; Ovens R; Chapman D; Bhalla V; Marks P; Hicks N; Fowler T; Hopkins S; Yardley L; Peto TEA
Lancet; 2021 Oct; 398(10307):1217-1229. PubMed ID: 34534517
[TBL] [Abstract][Full Text] [Related]
35. Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset.
Cheng HY; Jian SW; Liu DP; Ng TC; Huang WT; Lin HH;
JAMA Intern Med; 2020 Sep; 180(9):1156-1163. PubMed ID: 32356867
[TBL] [Abstract][Full Text] [Related]
36. Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study.
Eyre DW; Futschik M; Tunkel S; Wei J; Cole-Hamilton J; Saquib R; Germanacos N; Dodgson AR; Klapper PE; Sudhanva M; Kenny C; Marks P; Blandford E; Hopkins S; Peto TEA; Fowler T
Lancet Infect Dis; 2023 Aug; 23(8):922-932. PubMed ID: 37001541
[TBL] [Abstract][Full Text] [Related]
37. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity by Viral Load, S Gene Variants and Demographic Factors, and the Utility of Lateral Flow Devices to Prevent Transmission.
Lee LYW; Rozmanowski S; Pang M; Charlett A; Anderson C; Hughes GJ; Barnard M; Peto L; Vipond R; Sienkiewicz A; Hopkins S; Bell J; Crook DW; Gent N; Walker AS; Peto TEA; Eyre DW
Clin Infect Dis; 2022 Feb; 74(3):407-415. PubMed ID: 33972994
[TBL] [Abstract][Full Text] [Related]
38. Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases.
Trunfio M; Richiardi L; Alladio F; Staffilano E; Longo B; Venuti F; Ghisetti V; Burdino E; Bonora S; Vineis P; Di Perri G; Calcagno A
Front Microbiol; 2022; 13():829393. PubMed ID: 35432272
[TBL] [Abstract][Full Text] [Related]
39. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
40. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study.
Nomah DK; Reyes-Urueña J; Díaz Y; Moreno S; Aceiton J; Bruguera A; Vivanco-Hidalgo RM; Llibre JM; Domingo P; Falcó V; Imaz A; Cortés C; Force L; Letang E; Vilaró I; Casabona J; Miro JM;
Lancet HIV; 2021 Nov; 8(11):e701-e710. PubMed ID: 34655549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
